scholarly article | Q13442814 |
P50 | author | Kári Stefánsson | Q6453246 |
Torben Jørgensen | Q7825461 | ||
Augustine Kong | Q28050134 | ||
Gudmar Thorleifsson | Q28050150 | ||
Unnur Þorsteinsdóttir | Q28050158 | ||
Valgerdur Steinthorsdottir | Q28805350 | ||
Torben Hansen | Q29583803 | ||
Oluf Borbye Pedersen | Q29583849 | ||
Niels Grarup | Q29710540 | ||
Rafn Benediktsson | Q29840633 | ||
Patrick Sulem | Q29998686 | ||
Daníel F. Guðbjartsson | Q30348313 | ||
Torsten Lauritzen | Q30435282 | ||
Allan Linneberg | Q37392821 | ||
Johanne Marie Justesen | Q37640260 | ||
Marit E. Jørgensen | Q38219648 | ||
Henrik Vestergaard | Q47502437 | ||
Hafdis Helgadottir | Q56435892 | ||
Gísli Másson | Q58761857 | ||
Fereidoun Azizi | Q63695821 | ||
Ivan Brandslund | Q87944394 | ||
Asgeir Sigurdsson | Q88734369 | ||
Annelli Sandbaek | Q100693264 | ||
Cramer Christensen | Q114332574 | ||
Astradur B Hreidarsson | Q114332656 | ||
P2093 | author name string | Gunnar Sigurdsson | |
Agnar Helgason | |||
Hannes Helgason | |||
Sigurjon A Gudjonsson | |||
Hrefna Johannsdottir | |||
Olafur T Magnusson | |||
Mohammad-Sadegh Fallah | |||
Maryam S Daneshpour | |||
Marie N Harder | |||
P2860 | cites work | The human genome browser at UCSC | Q24672361 |
Statistical aspects of the analysis of data from retrospective studies of disease | Q27860916 | ||
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes | Q28272915 | ||
Genetics of gene expression and its effect on disease | Q29614591 | ||
Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor | Q29614870 | ||
A variant in CDKAL1 influences insulin response and risk of type 2 diabetes | Q29614878 | ||
NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy | Q29617901 | ||
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci | Q30425020 | ||
Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth | Q33758338 | ||
Probing the production of amidated peptides following genetic and dietary copper manipulations | Q34110252 | ||
Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion | Q34319297 | ||
The biosynthesis of neuropeptides: peptide alpha-amidation | Q34401086 | ||
Detection of sharing by descent, long-range phasing and haplotype imputation | Q34928818 | ||
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. | Q36508365 | ||
Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetes | Q36651827 | ||
Parental origin of sequence variants associated with complex diseases | Q37102209 | ||
Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. | Q37130357 | ||
A novel endonuclease IV post-PCR genotyping system | Q39117326 | ||
Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. | Q40051311 | ||
Common variants in WFS1 confer risk of type 2 diabetes | Q41852502 | ||
MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1. | Q43806860 | ||
Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits | Q44274525 | ||
A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. | Q44685218 | ||
The prevalence and morbidity of sensitization to fragrance mix I in the general population. | Q44901444 | ||
Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse | Q46753570 | ||
The gene encoding phosphodiesterase 4D confers risk of ischemic stroke | Q48185073 | ||
Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution | Q57278407 | ||
The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening | Q73152513 | ||
Early-onset type-II diabetes mellitus (MODY4) linked to IPF1 | Q73777239 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type 2 diabetes | Q3025883 |
P304 | page(s) | 294-298 | |
P577 | publication date | 2014-01-26 | |
P1433 | published in | Nature Genetics | Q976454 |
P1476 | title | Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes | |
P478 | volume | 46 |
Q38689236 | 10 Years of GWAS Discovery: Biology, Function, and Translation |
Q26775879 | 60 YEARS OF POMC: From POMC and α-MSH to PAM, molecular oxygen, copper, and vitamin C |
Q48561722 | A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction |
Q95723667 | A Genome-Wide Association Study to Identify Single-Nucleotide Polymorphisms for Acute Kidney Injury |
Q35761096 | A Splice Region Variant in LDLR Lowers Non-high Density Lipoprotein Cholesterol and Protects against Coronary Artery Disease |
Q59128914 | A hPSC-based platform to discover gene-environment interactions that impact human β-cell and dopamine neuron survival |
Q38752732 | An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans |
Q36367815 | Association Between KCNQ1 Genetic Variants and Type 2 Diabetes in the Uyghur Population |
Q50971133 | Association analysis of 29,956 individuals confirms that a low-frequency variant at CCND2 halves the risk of type 2 diabetes by enhancing insulin secretion. |
Q35715829 | Association between SLC30A8 rs13266634 Polymorphism and Type 2 Diabetes Risk: A Meta-Analysis |
Q35588251 | Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population |
Q35234550 | Association of genetic variants with hypertension in a longitudinal population-based genetic epidemiological study |
Q91865303 | Benefits and limitations of genome-wide association studies |
Q52364288 | CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition. |
Q35370064 | Can genomics help usher schizophrenia into the age of RDoC and DSM-6? |
Q92415198 | Ciliary and cytoskeletal functions of an ancient monooxygenase essential for bioactive amidated peptide synthesis |
Q34556382 | Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly |
Q38808702 | Common and rare forms of diabetes mellitus: towards a continuum of diabetes subtypes |
Q35333498 | Communication is the key. : Part 2 : Direct to consumer genetics in our future daily life ? |
Q90836055 | CpG-SNP site methylation regulates allele-specific expression of MTHFD1 gene in type 2 diabetes |
Q59401101 | Deeper, longer phenotyping to accelerate the discovery of the genetic architectures of diseases |
Q63916396 | Developing a network view of type 2 diabetes risk pathways through integration of genetic, genomic and functional data |
Q38816596 | Diabetes in Population Isolates: Lessons from Greenland |
Q47838387 | Diabetes: Still a geneticist's nightmare |
Q37613798 | Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps |
Q38843404 | Discovery of rare variants for complex phenotypes. |
Q44801223 | Diverse type 2 diabetes genetic risk factors functionally converge in a phenotype-focused gene network. |
Q30353921 | Early eukaryotic origins for cilia-associated bioactive peptide-amidating activity. |
Q47825022 | Effect of sequence variants on variance in glucose levels predicts type 2 diabetes risk and accounts for heritability. |
Q38667652 | Enrichment of low-frequency functional variants revealed by whole-genome sequencing of multiple isolated European populations |
Q37423792 | Epigenetic and genetic components of height regulation |
Q36172690 | Evaluating the Calibration and Power of Three Gene-Based Association Tests of Rare Variants for the X Chromosome |
Q64108431 | Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls |
Q48477844 | Exome-chip association analysis reveals an Asian-specific missense variant in PAX4 associated with type 2 diabetes in Chinese individuals. |
Q30840891 | Exploration of haplotype research consortium imputation for genome-wide association studies in 20,032 Generation Scotland participants |
Q64100517 | Exploring Impact of Rare Variation in Systemic Lupus Erythematosus by a Genome Wide Imputation Approach |
Q37048022 | Fast and accurate long-range phasing in a UK Biobank cohort |
Q48190008 | Functional Investigations of HNF1A Identify Rare Variants as Risk Factors for Type 2 Diabetes in the General Population |
Q49970697 | Genetic Approaches to the Study of Gene Variants and Their Impact on the Pathophysiology of Type 2 Diabetes |
Q36132996 | Genetic Effects on Longitudinal Changes from Healthy to Adverse Weight and Metabolic Status – The HUNT Study |
Q90746500 | Genetic Identification for Non-Communicable Disease: Findings from 20 Years of the Tehran Lipid and Glucose Study |
Q55272361 | Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes. |
Q98394707 | Genetic markers and continuity of healthy metabolic status: Tehran cardio-metabolic genetic study (TCGS) |
Q38214522 | Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond |
Q33921071 | Genetic variants including markers from the exome chip and metabolite traits of type 2 diabetes |
Q26745624 | Genetics of Insulin Resistance and the Metabolic Syndrome |
Q30250281 | Genetics of Type 2 Diabetes: the Power of Isolated Populations |
Q35227765 | Genetics of type 2 diabetes-pitfalls and possibilities |
Q38786129 | Genome-Wide Studies of Type 2 Diabetes and Lipid Traits in Hispanics |
Q50420617 | Genome-wide analysis yields new loci associating with aortic valve stenosis |
Q57417302 | Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes |
Q36536523 | Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes |
Q92610114 | Genome-wide association study identifies novel risk variants from RPS6KA1, CADPS, VARS, and DHX58 for fasting plasma glucose in Arab population |
Q36096515 | Genome-wide association study revealed genomic regions related to white/red earlobe color trait in the Rhode Island Red chickens |
Q64118849 | Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk |
Q62840254 | Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk |
Q63352628 | Genomic insights into the causes of type 2 diabetes |
Q39155009 | Genomics of Islet (Dys)function and Type 2 Diabetes |
Q37649339 | Glucose Induces Mouse β-Cell Proliferation via IRS2, MTOR, and Cyclin D2 but Not the Insulin Receptor |
Q46266920 | Glutathione S-transferase genes and the risk of type 2 diabetes mellitus: the role of sexual dimorphism, gene-gene and gene-smoking interactions in disease susceptibility. |
Q36232888 | Height-reducing variants and selection for short stature in Sardinia |
Q90523207 | High-Throughput Approaches onto Uncover (Epi)Genomic Architecture of Type 2 Diabetes |
Q57241781 | Historical Overview of Gene Discovery Methodologies in Type 2 Diabetes |
Q63916423 | Human Genetics of Obesity and Type 2 Diabetes Mellitus: Past, Present, and Future |
Q30234640 | Human genetics as a model for target validation: finding new therapies for diabetes |
Q34242898 | Identification of a novel gene for diabetic traits in rats, mice, and humans |
Q41247286 | Identification of candidate protective variants for common diseases and evaluation of their protective potential |
Q57363737 | Identification of novel high-impact recessively inherited type 2 diabetes risk variants in the Greenlandic population |
Q94544800 | Identifying novel associations in GWAS by hierarchical Bayesian latent variable detection of differentially misclassified phenotypes |
Q38705442 | Improving power for rare-variant tests by integrating external controls |
Q36581398 | Insertion of an SVA-E retrotransposon into the CASP8 gene is associated with protection against prostate cancer |
Q28088772 | Insights from exome sequencing for endocrine disorders |
Q26753207 | Insights into metabolic disease from studying genetics in isolated populations: stories from Greece to Greenland |
Q89882659 | Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics |
Q38262599 | Insights into the genetic susceptibility to type 2 diabetes from genome-wide association studies of glycaemic traits. |
Q30251397 | Islet biology, the CDKN2A/B locus and type 2 diabetes risk |
Q36254175 | Japonica array: improved genotype imputation by designing a population-specific SNP array with 1070 Japanese individuals |
Q34468572 | Large-scale whole-genome sequencing of the Icelandic population |
Q35533426 | Linkage and association analysis of obesity traits reveals novel loci and interactions with dietary n-3 fatty acids in an Alaska Native (Yup'ik) population |
Q83225950 | Linking glycemic dysregulation in diabetes to symptoms, comorbidities, and genetics through EHR data mining |
Q39608334 | Low-, high-coverage, and two-stage DNA sequencing in the design of the genetic association study |
Q38652238 | Mechanisms of Type 2 Diabetes Risk Loci |
Q38219242 | Methodology for the analysis of rare genetic variation in genome-wide association and re-sequencing studies of complex human traits |
Q36960085 | Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes |
Q35487317 | New basal cell carcinoma susceptibility loci |
Q26795455 | New insights from monogenic diabetes for "common" type 2 diabetes |
Q47242206 | Novel methods for genotype imputation to whole-genome sequence and a simple linear model to predict imputation accuracy |
Q50136290 | Obesity genetics: insights from the Pakistani population |
Q36600267 | On Efficient and Accurate Calculation of Significance P-Values for Sequence Kernel Association Testing of Variant Set. |
Q38246134 | Overlap of genetic susceptibility to type 1 diabetes, type 2 diabetes, and latent autoimmune diabetes in adults. |
Q38595515 | Pacific Populations, Metabolic Disease and 'Just-So Stories': A Critique of the 'Thrifty Genotype' Hypothesis in Oceania |
Q38803129 | Pancreatic Islet Protein Complexes and Their Dysregulation in Type 2 Diabetes |
Q47864520 | Peripheral Arterial Disease Genetics: Progress to Date and Challenges Ahead |
Q28274686 | Pharmacogenomics in diabetes mellitus: insights into drug action and drug discovery |
Q50046253 | Precision nutrition for prevention and management of type 2 diabetes |
Q33660160 | Prediction of gene expression with cis-SNPs using mixed models and regularization methods |
Q38652496 | Prioritising Causal Genes at Type 2 Diabetes Risk Loci |
Q91659453 | QTL-mapping and genomic prediction for bovine respiratory disease in U.S. Holsteins using sequence imputation and feature selection |
Q38775863 | Quantifying the extent to which index event biases influence large genetic association studies |
Q48174705 | Rare and Common Variants Conferring Risk of Tooth Agenesis. |
Q29583867 | Rare and low-frequency coding variants alter human adult height |
Q38245817 | Rare and low-frequency variants in human common diseases and other complex traits |
Q35961979 | Rare coding variants and X-linked loci associated with age at menarche |
Q35110309 | Rare variant association studies: considerations, challenges and opportunities |
Q26852733 | Rare-variant association analysis: study designs and statistical tests |
Q48190503 | Re-analysis of public genetic data reveals a rare X-chromosomal variant associated with type 2 diabetes |
Q92298240 | Recent advances and perspectives in next generation sequencing application to the genetic research of type 2 diabetes |
Q36065329 | Recent advances in understanding the genetic architecture of type 2 diabetes |
Q26766482 | Recent progress in genetic and epigenetic research on type 2 diabetes |
Q52327404 | Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. |
Q34265051 | Repurposing cAMP-modulating medications to promote β-cell replication. |
Q38781016 | Resetting the bar: Statistical significance in whole-genome sequencing-based association studies of global populations. |
Q92662384 | Rewriting Human History and Empowering Indigenous Communities with Genome Editing Tools |
Q89574589 | Rho Guanine Nucleotide Exchange Factor ARHGEF17 Is a Risk Gene for Intracranial Aneurysms |
Q35982039 | Sequence Kernel Association Analysis of Rare Variant Set Based on the Marginal Regression Model for Binary Traits |
Q28550151 | Sequence to Medical Phenotypes: A Framework for Interpretation of Human Whole Genome DNA Sequence Data |
Q33786392 | Sequence variants in ARHGAP15, COLQ and FAM155A associate with diverticular disease and diverticulitis |
Q36871093 | Sequence-based Association Analysis Reveals an MGST1 eQTL with Pleiotropic Effects on Bovine Milk Composition |
Q96233486 | Sequencing and imputation in GWAS: Cost-effective strategies to increase power and genomic coverage across diverse populations |
Q45981116 | Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals. |
Q28081028 | Strategies for Imputing and Analyzing Rare Variants in Association Studies |
Q48258090 | TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH). |
Q64066397 | The Contribution of Low-Frequency and Rare Coding Variation to Susceptibility to Type 2 Diabetes |
Q57924792 | The Hunt for Low-Frequency Alleles Predisposing to Type 2 Diabetes and Related Cardiovascular Risk Factors |
Q40365893 | The Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases |
Q90205461 | The Māori and Pacific specific CREBRF variant and adult height |
Q35927955 | The contribution of protein intrinsic disorder to understand the role of genetic variants uncovered by autism spectrum disorders exome studies. |
Q29583824 | The genetic architecture of type 2 diabetes |
Q33613854 | The impact of rare and low-frequency genetic variants in common disease |
Q34499691 | The pancreatic β cell: recent insights from human genetics |
Q47122658 | The peptidylglycine-α-amidating monooxygenase (PAM) gene rs13175330 A>G polymorphism is associated with hypertension in a Korean population |
Q39821664 | Transcriptomics in type 2 diabetes: Bridging the gap between genotype and phenotype |
Q48258271 | Truncating mutations in RBM12 are associated with psychosis |
Q63916436 | Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic β-cells |
Q30390388 | Type 2 diabetes: genetic data sharing to advance complex disease research |
Q34624781 | Using genetically isolated populations to understand the genomic basis of disease |
Q34271027 | Variants associated with type 2 diabetes identified by the transethnic meta-analysis study: assessment in American Indians and evidence for a new signal in LPP. |
Q39804212 | Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease |
Q37376704 | Vejle Diabetes Biobank - a resource for studies of the etiologies of diabetes and its comorbidities |
Q30373501 | Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis. |
Q35063173 | Whole-genome sequencing to understand the genetic architecture of common gene expression and biomarker phenotypes |
Q90675233 | Wnt/β-Catenin Signaling and Obesity |